The Lancets Market is estimated at US$6.9 billion in 2026 and is projected to grow at a CAGR of 6.9% to reach US$11.8 billion by 2034.
Relevant uses and settings include diabetes management, hospital testing, home care monitoring, diagnostic sampling, community healthcare, and outpatient screening. Commercial considerations include category commoditization, reimbursement pressure, waste management concerns, and competition on price in a highly standardized product segment.
This product will be delivered within 1-3 business days.
Market Overview
The Lancets Market covers small medical devices used to obtain capillary blood samples for glucose testing, diagnostics, and point of care monitoring in clinical and home settings.Relevant uses and settings include diabetes management, hospital testing, home care monitoring, diagnostic sampling, community healthcare, and outpatient screening. Commercial considerations include category commoditization, reimbursement pressure, waste management concerns, and competition on price in a highly standardized product segment.
Key Companies Analysed
- Roche
- Abbott
- Becton, Dickinson and Company
- Terumo Corporation
- B. Braun
- ARKRAY
- Nipro Corporation
- Greiner Bio-One
- Sarstedt
- Medtronic
- Trividia Health
- Omnis Health
- ACON Laboratories
- VivaChek Biotech
- HTL-STREFA
- Ypsomed
- AgaMatrix
- LifeScan
- Ascensia Diabetes Care
- Owen Mumford
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Lancets Market Overview
3. Lancets Market Dynamics
4. Lancets Market Strategic Analysis
5. Global Lancets Market Size, Share and Forecast, 2025-2034
6. North America Lancets Market Outlook to 2034
7. Europe Lancets Market Outlook to 2034
8. Asia-Pacific Lancets Market Outlook to 2034
9. Middle East and Africa Lancets Market Outlook to 2034
10. South and Central America Lancets Market Outlook to 2034
11. Lancets Market Competitive Landscape
12. Appendix
Companies Mentioned
- Roche
- Abbott
- Becton, Dickinson and Company
- Terumo Corporation
- B. Braun
- ARKRAY
- Nipro Corporation
- Greiner Bio-One
- Sarstedt
- Medtronic
- Trividia Health
- Omnis Health
- ACON Laboratories
- VivaChek Biotech
- HTL-STREFA
- Ypsomed
- AgaMatrix
- LifeScan
- Ascensia Diabetes Care
- Owen Mumford
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value in 2026 | 6.9 Billion |
| Forecasted Market Value by 2034 | 11.8 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
